Tazama kwenye Tovuti Rasmi Fanya biashara kwa pesa halisi kwenye Polymarket →

Odds & FAQ

What are the current odds for FDA approves Daraxonrasib this year?

Ndio is priced at 89% and Hapana at 11%, based on live Polymarket order-book trading. Prices move in real time as traders buy and sell.

What do traders predict for FDA approves Daraxonrasib this year?

Traders currently imply a 89% chance for Ndio. Market-implied probabilities reflect real money at stake, but they are live forecasts that shift as new information arrives, not guarantees.

When does the FDA approves Daraxonrasib this year market resolve?

This market is scheduled to resolve on 31 Dec 2026 (Siku 128 zimebaki). It settles according to Polymarket's published resolution criteria once the outcome is confirmed.

How much money is trading on FDA approves Daraxonrasib this year?

Total traded volume on this market is $2.6K, a measure of how much real money traders have committed to the outcome.

How can I trade FDA approves Daraxonrasib this year on Polymarket?

You can follow the live odds on this page and open the market on Polymarket to trade it yourself. Prediction trading carries risk; never stake more than you can afford to lose.